Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CHKA | P35790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18136192 | 0.82 | KDM4E (0.45) | — | |
| SCHEMBL21230341 | 0.81 | CA2 (0.37) | QRFPRTRPV4CA2CHKA | |
| SCHEMBL19974425 | 0.81 | QRFPR (0.33) | QRFPRTRPV4CA2CHKA | |
| SCHEMBL21065788 | 0.81 | ALOX15 (0.32) | QRFPRTRPV4CA2CHKA | |
| SCHEMBL29538895 | 0.81 | QRFPR (0.33) | QRFPRTRPV4CA2CHKA | |
| SCHEMBL25888568 | 0.79 | CNR2 (0.35) | QRFPRTRPV4 | |
| SCHEMBL21698353 | 0.78 | MCHR1 (0.34) | QRFPRMCHR1 | |
| SCHEMBL20100075 | 0.78 | S1PR1 (0.36) | QRFPR | |
| SCHEMBL22436278 | 0.77 | — | — | |
| SCHEMBL19712050 | 0.76 | S1PR1 (0.35) | QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512847-B1 | PROCESS FOR THE PREPARATION OF HALOGENATED BICYCLES | BAYER CROPSCIENCE AG (DE) | 2022-03-30 | — | — | EP | disclosed |
| US-20190375766-A1 | PROCESS FOR PREPARING HALOGENATED BICYCLIC SYSTEMS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-12-12 | — | — | US | disclosed |
| EP-3512847-A1 | METHOD FOR PRODUCING HALOGENATED BICYCLIC COMPOUNDS | Bayer CropScience Aktiengesellschaft (DE) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018050515-A1 | METHOD FOR PRODUCING HALOGENATED BICYCLIC COMPOUNDS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190375766-A1 | PROCESS FOR PREPARING HALOGENATED BICYCLIC SYSTEMS | INTS6, POLR2H, NQO2 | QRFPR 746/4885DHODH 1295/4885MCHR1 2514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.